Medication info
Diaryl Tablet 4 mg (Glymeperide)

Diaryl Tablet 4 mg (Glymeperide)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Darim Biotech Co., Ltd.
Appearance
Light blue rectangular tablets
Packaging
For domestic use: 100 tablets/bottle, 30 tablets/bottle; For export: 100 tablets/bottle, 30 tablets/bottle, 30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 200706320 · Notified 2007.06.01 · Insurance code 664600450

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended that the instructions under Initial dose be followed. That is, initiate treatment with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial treatment when a sulfonylurea is administered. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Darim Biotech Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used to complement dietary and exercise therapy to improve blood glucose control in patients with type 2 diabetes. It may be used alone or in combination with oral hypoglycemic agents or insulin when blood glucose control is inadequate or difficult. In particular, it is used in combination with metformin when control is not achieved with sulfonylureas or monotherapy with metformin. It helps patients manage their blood sugar levels more effectively, thereby improving blood glucose management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended that the instructions under Initial dose be followed. That is, initiate treatment with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial treatment when a sulfonylurea is administered. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylurea agents, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients who have had an allergic reaction to this medication or to sulfonylureas should not take it. There is no experience with severe liver or kidney dysfunction, and switching to insulin therapy is recommended. Women who are pregnant or nursing should not take this medication, and patients with severe infections, major surgeries, or severe trauma should receive insulin treatment. Care is required when there are gastrointestinal issues, as food absorption may be impaired, increasing the risk of hypoglycemia. This medication is contraindicated in patients with genetic lactose intolerance. During the first week of taking this medication, there is a high risk of hypoglycemia, so blood sugar should be monitored frequently. Particular caution is required for the elderly, patients in poor nutritional status, those who skip meals, individuals with an imbalance between exercise and food intake, people who consume a lot of alcohol, and those with reduced liver or kidney function. Additionally, individuals with other endocrine disorders or those taking multiple medications may also have an increased risk of hypoglycemia. If hypoglycemic symptoms appear, immediate intake of sugar is necessary, and if symptoms are severe, medical personnel should be informed. Taking this medication may cause hypoglycemic symptoms such as headache, hunger, nausea, fatigue, confusion, drowsiness, loss of consciousness, etc. Vision changes, gastrointestinal problems, liver function abnormalities, blood abnormalities, and allergic reactions may also occur; if any unusual symptoms arise, consult a doctor immediately. Severe hypoglycemia or allergic reactions can be life-threatening, requiring prompt treatment. To control blood sugar, this medication should be taken regularly, along with dietary measures and exercise. To prevent hypoglycemia, always carry sugar, and ensure that family members understand the hypoglycemic symptoms and treatment methods. In stressful situations, surgeries, or infections, blood sugar control may become more difficult, so consultation with a physician is necessary. This medication may interact with other drugs, so if you are taking other medications, you must inform your doctor. Particular blood sugar changes may occur when taken with certain antibiotics, antifungals, beta-blockers, and steroids. It is best to avoid use during pregnancy or breastfeeding as it may affect the fetus and newborn. Safety and efficacy have not been established in children under 18 years of age. Elderly patients should be careful with dosage adjustment due to potential decreased kidney function. In cases of overdose, severe hypoglycemia can occur, necessitating immediate emergency treatments such as inducing vomiting, blocking drug absorption, or administering intravenous glucose. Keep out of reach of children and store in the original container to prevent drug misuse and degradation of quality.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disturbance
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • reduced agility or activity
  • depression
  • confusion
  • language abnormalities
  • aphasia
  • visual impairment
  • tremor
  • incomplete paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • cerebral convulsions
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina pectoris
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • phototoxic reactions of the skin
  • decreased serum sodium concentration
  • dysgeusia
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light blue rectangular tablets

Package unit

For domestic use: 100 tablets/bottle, 30 tablets/bottle; For export: 100 tablets/bottle, 30 tablets/bottle, 30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.